Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Viral vaccine for the treatment of viral disease

A viral disease and virus technology, applied in antiviral agents, viral antigen components, etc., can solve the problems of no progress, harm, and large toxic and side effects of viral diseases

Inactive Publication Date: 2005-06-22
公殿力
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Antibiotics do not work against viruses, they are only used to control the secondary infection of bacteria, so it is often seen that after several injections (intravenous drip), there is no improvement, but the abuse of antibiotics has caused great harm to the human body
[0006] Drugs for the treatment of viral diseases also include antisense RNA and therapeutic vaccines (such as hepatitis B vaccine for hepatitis B; herpes simplex vaccine for herpes simplex virus infection). In the research stage, it cannot be used in clinical practice on a large scale
[0007] The therapies for the treatment of viral diseases described above have certain curative effects on viral diseases, but each therapy has certain defects, such as unsatisfactory curative effect, large toxic and side effects, small application range, poor specificity, etc.
At present, traditional therapy has made little progress in the treatment of viral diseases, such as new viral diseases SARS and avian influenza, and there is still no effective treatment method so far

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0045] Example 1. Clinical Trials

[0046] In a clinical trial, 10 patients (5 children, 5 adults) with viral influenza were treated with a viral vaccine (measles live attenuated vaccine). Among the 10 patients, the fever was above 38 degrees, accompanied by cold symptoms. Children are injected with 1ml of vaccine, and adults are injected with 2ml of vaccine. After 12-24 hours, the fever will be reduced and the body temperature will reach normal. After resting for 1-2 days, all cold symptoms will disappear and the patient will be cured.

Embodiment 2

[0047] Example 2. Clinical trials

[0048] In a clinical trial, 2 cases of rubella in children were treated with a virus vaccine (live attenuated mumps vaccine), and the patients presented symptoms such as fever and skin rash. Inject 1ml of the vaccine, within 12-24 hours, the fever will subside and reach normal body temperature, and then rest for 3-5 days, all skin rashes will disappear, that is to say, healed.

Embodiment 3

[0049] Example 3. Clinical trials

[0050]In a clinical trial, a child with chickenpox was treated with a virus vaccine (attenuated rubella live vaccine), and the patient presented with symptoms such as fever and chickenpox on the skin. Inject 1ml of the vaccine, within 24 hours, the fever subsides, reaches normal body temperature, no new chickenpox appears, and rests for another 5 days, all the skin chickenpox is cured and disappears, that is to say, healed.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Disclosed is a method for treating virosis, wherein viruses causing virosis can be killed by multiple antiviral proteins produced by interferon evoked cells generated by virus type vaccine stimulation organism, thus curing the virosis. Different dosage, administration mode and and time can be employed for the patients.

Description

Background of the invention [0001] Viral diseases are caused by viruses and can spread among people. Viruses are widely distributed in nature and there are various types, which can cause diseases in humans, animals and plants. 80% of human infectious diseases are caused by viruses, especially in infants and children. Viral diseases are highly contagious and widespread (such as influenza), some have sequelae (such as polio), and some have high mortality (such as AIDS, Ebola virus infection). In addition, viruses are closely related to the occurrence of tumors, and a variety of animal tumors have been confirmed to be caused by viruses, so humans are closely related to viruses. In the past 50 years, many new viral diseases that endanger human health have been discovered, such as AIDS, Ebola virus infection, SARS, bird flu and so on. Among them, Ebola virus, Lassa fever virus, Marburg virus, West Nile virus, dengue virus, Machopo virus and other virus infections have extremely ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K39/12A61P31/12
Inventor 公殿力
Owner 公殿力
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com